TAPARO ANTHONY

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$8.28M

Insider Activity of TAPARO ANTHONY

The largest sale of all time was on 2021-05-10 and amounted to 127176 shares of Surgery Partners, Inc. for $6.43M.

Biography of TAPARO ANTHONY

No biography is available at this moment.

2024-03-12SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
787
0.0006%
$29.87$23,508-13%
2024-03-11SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
651
0.0005%
$29.54$19,231-12.55%
2024-03-05SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
1,347
0.0011%
$30.70$41,353-14.43%
2024-02-13SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
1,100
0.0008%
$33.40$36,740-17.17%
2023-03-15SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
32
<0.0001%
$30.10$963+5.86%
2023-03-14SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
4,067
0.0032%
$31.11$126,524+5.62%
2023-03-13SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
1,509
0.0012%
$30.09$45,406+9.2%
2023-02-27SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
6,582
0.0052%
$33.52$220,629-2.68%
2023-02-13SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
1,085
0.0009%
$33.91$36,792-3.17%
2022-03-24SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
5,000
0.0057%
$53.50$267,500-40.82%
2022-03-15SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
7,426
0.0082%
$49.30$366,102-36.7%
2022-03-11SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
1,320
0.0015%
$55.00$72,600-40.37%
2022-02-28SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
11,306
0.0129%
$52.28$591,078-37.96%
2021-05-10SaleSurgery Partners, Inc.
SGRY
Chief Growth Officer
127,176
0.184%
$50.55$6.43M+0.06%
Total: 14
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.